LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza

News (ZH) - Research use only reagents allows detection of SARS-CoV-2, influenza A, and influenza B from a single patient sample

LGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing

News (ZH) - Product designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics

National Measurement Laboratory at LGC has expanded its portfolio of reference materials

News (ZH) - Characterised for sulfur dioxide content traceable to the SI

Euan O’Sullivan promoted to President & Chief Operating Officer

News (ZH) - President and COO for the group

LGC reports half year trading in line with expectations

News (ZH) - Management confirms that trading is in line with expectations, with strong momentum expected to continue through the second half of the year to 31 March 2021

LGC acquires SAFEFOOD 360°, expanding its supply chain assurance offering

News (ZH) - Safefood 360° supports compliance with major food safety and supplier management requirements

LGC's Anti-SARS-CoV-2 controls kit now CE Marked

News (ZH) - CE mark and IVD symbol signifies that ACCURUN Anti-SARS-CoV-2 Controls Kit meets extensive design control requirements

LGC’s high-throughput PCR testing system for SARS-CoV-2 detection, submitted for Emergency Use Authorisation, capable of processing up to 35,000 tests per day

News (ZH) - Testing labs can now leverage LGC’s unrivalled expertise in automated sample preparation and high-throughput RT-PCR workflows

LGC offers regulated bioanalysis on the SCIEX TripleTOF® 6600 High-Resolution Mass Spectrometry platform

News (ZH) - Platform offers alternative tool for quantification of therapeutics and biomarkers from within complex biological matrices

LGC signs pre-let for new R&D facility at Oxford Technology Park

News (ZH) - Site will accommodate mixture of bespoke laboratory, office and logistics operations